INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2011

A new post-epidemic case of eosinophilia-myalgia syndrome was reported in association with L-tryptophan consumption.

This case report describes a new case of eosinophilia-myalgia syndrome (EMS) associated with L-tryptophan following the lifting of the FDA ban in 2005. The report details clinical, histopathologic, and immunogenetic features of the patient. In addition, evidence of activated transforming growth factor β and interleukin-4 signaling was identified in the lesional skin.

Shows an association, not proof of cause and effect.

Study type
Case report
Who was studied
A patient with L-tryptophan-associated eosinophilia-myalgia syndrome
What was measured
Clinical, histopathologic, and immunogenetic features

THE PAPER

Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.

Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J. Arthritis Rheum, 2011.

PubMed 21702023 ↗DOI 10.1002/art.30514 ↗

Food safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.